CN1171943A - Chinese medicinal preparation for treating heart disease - Google Patents
Chinese medicinal preparation for treating heart disease Download PDFInfo
- Publication number
- CN1171943A CN1171943A CN 96110885 CN96110885A CN1171943A CN 1171943 A CN1171943 A CN 1171943A CN 96110885 CN96110885 CN 96110885 CN 96110885 A CN96110885 A CN 96110885A CN 1171943 A CN1171943 A CN 1171943A
- Authority
- CN
- China
- Prior art keywords
- heart disease
- heart
- chinese medicine
- kidney
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 208000019622 heart disease Diseases 0.000 title abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 31
- 230000003130 cardiopathic effect Effects 0.000 claims description 11
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 6
- 235000008434 ginseng Nutrition 0.000 claims description 6
- 241000237903 Hirudo Species 0.000 claims description 5
- 241000237636 Pheretima Species 0.000 claims description 5
- 241000180649 Panax notoginseng Species 0.000 claims description 4
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 4
- 241000208340 Araliaceae Species 0.000 claims 1
- 210000002216 heart Anatomy 0.000 abstract description 17
- 210000003734 kidney Anatomy 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 12
- 230000007812 deficiency Effects 0.000 abstract description 8
- 244000131316 Panax pseudoginseng Species 0.000 abstract description 7
- 208000024891 symptom Diseases 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 3
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract description 2
- 230000007246 mechanism Effects 0.000 abstract description 2
- 241000545744 Hirudinea Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 235000002789 Panax ginseng Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 11
- 208000029078 coronary artery disease Diseases 0.000 description 8
- 238000010586 diagram Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 206010003658 Atrial Fibrillation Diseases 0.000 description 4
- 206010003119 arrhythmia Diseases 0.000 description 4
- 230000006793 arrhythmia Effects 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 208000031225 myocardial ischemia Diseases 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000010247 heart contraction Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 208000011726 slow pulse Diseases 0.000 description 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010040639 Sick sinus syndrome Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000023482 precordial pain Diseases 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal preparation for treating heart diseases. The formula comprises 1 to 3 parts of red ginseng, 0.5 to 1.5 parts of leech, 0.5 to 2 parts of earthworm and 0.5 to 2 parts of pseudo-ginseng. The invention considers that the kidney and the heart are inseparable, the deficiency of the kidney and blood stasis are the main mechanisms of the heart disease, and the tonifying of the kidney and the activation of blood are effective ways for treating the heart disease. The traditional Chinese medicine preparation provided by the invention is used for carrying out syndrome differentiation treatment on the heart disease by adopting a kidney tonifying and blood circulation activating method. The total effective rate reaches 100 percent, wherein the rate of completely relieving the symptoms is 92 percent.
Description
The present invention relates to the cardiopathic Chinese medicine preparation of a kind of treatment, mainly be suitable for the treatment of coronary heart disease, myocarditis, hypertensive cardiopathy, pulmonary heart disease, angina pectoris, arrhythmia and cardiac insufficiency.
More cardiopathic medicines of treatment commonly used clinically at present, range of application has certain limitation, and for the heart disease of some type, its curative effect is also not obvious.The Chinese People's Liberation Army's second big gun school Xi'an traditional Chinese medical science multidisciplinary research " SHANHAI PILL " interrelated data of publishing in 92 years show that " SHANHAI PILL " this Chinese medicine preparation is only limited to the treatment coronary artery disease with deficiency of both qi and yin, and technology is complicated.
The purpose of this invention is to provide the cardiopathic Chinese medicine preparation of a kind of new treatment, this preparation has more obvious curative effect to polytype heart disease.
The purpose of invention realizes by following mode.
In recent years, along with going deep into of heart disease rule of treatment research, be that this, blood stasis are that target understanding is gradually consistent for insufficiency of heart-QI, and ignored the function of kidney.The present invention is according to theory of Chinese medical science, and about research data and long-term clinical practice, thinking has inseparable relation between kidney and the heart in conjunction with modern, suffers from a deficiency of the kidney, blood stasis is the main mechanism that heart is fallen ill, and invigorating kidney, promoting blood circulation is to treat cardiopathic effective way.
According to the Therapeutic Method of invigorating kidney, promoting blood circulation, the prescription of the cardiopathic Chinese medicine preparation of treatment provided by the invention comprises Radix Ginseng Rubra 1-3 part, Hirudo 0.5-1.5 part, Pheretima 0.5-2 part.As a rule, this prescription also comprises Radix Notoginseng 0.5-2 part.
In prescription, the Radix Ginseng the kidney invigorating.Modern medicines studies have shown that Radix Ginseng is the representative that adapts to the former state effect, existing YANG invigorating, again the effect of YIN nourishing are arranged.Hirudo in the prescription, Pheretima and pseudo-ginseng blood-circulation-invigovating blood stasis dispelling.Invigorating kidney, promoting blood circulation is refinforced each other and is reached the cardiopathic purpose of treatment.
Studies show that according to clinical practice result and modern Chinese medicine the cardiopathic Chinese medicine preparation of treatment provided by the present invention has the effect of following several respects:
1, strengthen myocardial contraction, dilating coronary blood vessel increases blood supply of cardiac muscle, improves myocardial metabolism, reduces myocardial oxygen consumption, microcirculation improvement.
2, anticoagulant promotes fibrinolytic, suppresses platelet and erythrocyte aggregation, reduces blood viscosity, suppresses thrombosis and thrombus.
3, blood fat reducing, the formation that suppresses and remove atherosclerotic plaque.
4, strengthen the human body resistance, improve the heart, brain, kidney circulation and functional status.
5, correct arrhythmia, and adjust blood pressure (arrhythmia comprises: chamber, room property, atrial fibrillation, tachycardias are slow excessively).
6, the recovery of expansion of cerebral vascular, improvement circulation, promotion neurocyte function alleviates cerebral tissue inflammatory reaction and edema.
7, has regulating action to nervous system and hormonal system.
Amount to 1048 examples with this Chinese medicine preparation treatment heart disease, wherein complete relief of symptoms person 966 examples, produce effects person's 82 examples.Total effective rate reaches 100%, and the symptom complete remission rate is 92%, and with the prolongation of medicine time, curative effect increases gradually passs.
Chinese medicine preparation of the present invention adopts the invigorating kidney, promoting blood circulation method that heart disease is carried out dialectical executing and controls, and has obtained satisfied remarkable result.Practicality shows that said preparation is not still treated cardiopathic good recipe, also is the good medicine of treatment cerebrovascular.The medical material availability of said preparation and bioavailability height, clinical efficacy obviously is better than medicines such as " SHANHAI PILL ", and technology is simple, and dosage is little, nontoxic pair of effect.
Describe the present invention below.
Treat cardiopathic Chinese medicine preparation, its prescription (calculating by weight) comprises Radix Ginseng Rubra 1-3 part, Hirudo 0.5-1.5 part, Pheretima 0.5-2 part.This prescription is a basic recipe of the present invention.But as a rule, this prescription also should comprise Radix Notoginseng 0.5-2 part.
The dosage form of Chinese medicine preparation generally can adopt capsular form.Each composition is pulverized in proportion (medicated powder is about 200 orders) mixing, incapsulated and get final product.
According to the difference of the state of an illness, above-mentioned prescription can with other drug composition adapted, from rare following five kinds of application methods.
1, adapted 1-2 Radix Ophiopogonis part, Fructus Schisandrae Chinensis 1-2 part.
2, adapted Radix Aconiti Lateralis Preparata 1.5-4 part.
3, adapted Radix Puerariae 1.5-2.5 part, Radix Salviae Miltiorrhizae 1.5-2.5 part, Lignum Dalbergiae Odoriferae 0.5-2 part.
4, adapted 1-2 Radix Ophiopogonis part, Fructus Schisandrae Chinensis 1-2 part, Radix Paeoniae Rubra 1-2 part, Radix Angelicae Sinensis 0.5-1.5 part.
5, adapted 1-2 Radix Ophiopogonis part, Fructus Schisandrae Chinensis 1-2 part, Radix Aconiti Lateralis Preparata 1.5-3 part.
Subordinate list provides the example of eight basic recipes and other drug adapted.Wherein the 1st example mainly is applicable to deficiency of both QI and YIN, heart arteries and veins blood stasis blocking type heart disease, the 2nd and the 6th example mainly are applicable to QI and blood deficiency, heart arteries and veins blood stasis blocking type heart disease, the 3rd and the 7th example mainly are suitable for gas negative and positive three void, heart arteries and veins blood stasis blocking type heart disease, the 4th and the 8th example mainly are applicable to gas sun deficiency heart disease, and the 5th example mainly is applicable to the stagnation of QI, the deficiency of vital energy, heart arteries and veins blood stasis blocking type coronary heart disease.
Several cases are provided below.
1, in clear spring, man, 63 years old, northern station, Jiaozhuo retired employees.Suffered from coronary heart disease, atrial fibrillation medical history 20 years, and took medicine for a long time, be interrupted hospitalization, increase the weight of but have during the state of an illness.Take nervous before this medicine, heart beating is hard to bear, breathe hard, uncomfortable in chest, electrocardiogram shows that the atrial fibrillation heart rate is 120 times/minute, myocardial ischemia.Take preparation of the present invention (1) number (shown in subordinate list) after 1 hour symptom obviously alleviate, the rhythm of the heart is 80 times/minute after two days, arrhythmia still, but do not have sense of discomfort, electrocardio diagram atrial fibrillation, heart rate 80 times/minute, myocardial ischemia obviously improves.
2, Zhang Ronghou, man, 75 years old.Retired employees of Jiaozuo City local products company.Suffer from surplus hypertension, coronary heart disease, the cerebral thrombosis medical history ten year, be interrupted in the People's Hospital, city for a long time, city institute of traditional Chinese medicine accepts western medicines in treatment in hospital, all taken a turn for the better and left hospital.But patient can only hold up height to step on walking, and trembling of limbs, stifling, nervous often have angina pectoris attacks, and yellow complexion withers, lip pale tongue, stringy and thready pulse.With this medicine (2) number treatment three days, angina pectoris did not appear in stifling, the nervous disappearance, and extremity are strong, and the energy out-of-bed activity can be by bike after March.
3, Zhang Chaoxuan, man, 50 years old.Hypertension, coronary heart disease 4 years, cerebral hemorrhage medical history 2 years, private prosecution: stifling, nervous, heart beating is breathed hard, myasthenia of limbs, two lower limbs edema, frequent urination at night, does not have the obvious symptoms of chill and fever, corpulent tongue, dark, the stringy and slow pulse of color, BP20/12KPa, heart rate 42 times/minute, premature beat are per minute 8 times, the electrocardio diagram, myocardial ischemia, damage, ventricular premature contraction 8 times/minute.With this medicine (3) after number half an hour symptom obviously alleviate, next day transference cure, heart rate is 68 times/minute, rule is neat, three days two lower limb are edema not, once took month surplus, so far in order.
4, Wang Hanting, man, 57 years old.Be coronary heart disease by being examined before 5 years, sick sinus syndrome, feel oppressed in conscious ambition, breathe hard, the time pain is arranged, loose stool, the white deep-slow pulse of pale tongue tongue, the electrocardio diagram: heart rate 46 times/minute, myocardium extensive ischemia is taken day no any effect surplus " SHANHAI PILL " 100.This disease is a gas sun deficiency heart disease.Take this medicine (4) number after one hour, stifling, breathing hard alleviates, and next day, heart rate was 56-60 time/minute, and heart rate is 72 times/minute after three days, has not had sense of discomfort, takes two and half no significant discomfort senses so far after February.
5, Qi Shunxiu, woman, 50 years old.Coronary disease medical history 2 years is taken " compound Salviae Miltiorrhizae ", " XINNAOKANG ", " quick-acting effect heart ball " treatment for a long time, feels stifling in the time of still, has palpitation, breathes hard, sometimes precordial pain.Electrocardio diagram: myocardial ischemia, patient's dark tongue quality, visible petechia.After taking this medicine (5) number, do not occur above-mentioned symptom again, serve on 100 days, the electrocardio diagram: the no ischemia of cardiac muscle, patient is good so far.
Subordinate list:
| Composition weight portion group number | Radix Ginseng Rubra | Pheretima | Hirudo | Radix Notoginseng | Radix Ophiopogonis | Fructus Schisandrae Chinensis | Radix Paeoniae Rubra | Radix Angelicae Sinensis | Radix Aconiti Lateralis Preparata | Radix Puerariae | Radix Salviae Miltiorrhizae | Lignum Dalbergiae Odoriferae |
| ????(1) | ????1.5 | ????2 | ????1 | ???1.5 | ???1.5 | ??1.5 | ||||||
| ????(2) | ????1.5 | ????1 | ????1 | ???0.5 | ???1.5 | ??1.5 | ??1.5 | ??1 | ||||
| ????(3) | ????2 | ????1.5 | ????0.5 | ???0.5 | ???1.5 | ??1.5 | ??2 | |||||
| ????(4) | ????3 | ????1.5 | ????1 | ???0.5 | ??3 | |||||||
| ????(5) | ????1 | ????1 | ????0.5 | ???1.5 | ??2 | ??2 | ??1 | |||||
| ????(6) | ????1.5 | ????2 | ????1 | ???1.5 | ??1.5 | ??1.5 | ??1 | |||||
| ????(7) | ????2 | ????1.5 | ????0.5 | ???1.5 | ??1.5 | ??2 | ||||||
| ????(8) | ????3 | ????1.5 | ????1.5 | ??4 | ||||||||
Claims (5)
1, treat cardiopathic Chinese medicine preparation, prescription comprises Radix Ginseng Rubra 1-3 part, Hirudo 0.5-1.5 part, Pheretima 0.5-2 part.
2,, also comprise Radix Notoginseng 0.5-2 part in its prescription by the described Chinese medicine preparation of claim 1.
3,, also comprise 1-2 part Radix Ophiopogonis, Fructus Schisandrae Chinensis 1-2 part in its prescription by claim 1 or 2 described Chinese medicine preparation.
4,, also comprise Radix Aconiti Lateralis Preparata 1.5-4 part in its prescription by claim 1 or 2 described Chinese medicine preparation.
5,, also comprise Radix Puerariae 1.5-2.5 part, Radix Salviae Miltiorrhizae 1.5-2.5 part, Lignum Dalbergiae Odoriferae 0.5-2 part in its prescription by claim 1 or 2 described Chinese medicine preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96110885 CN1171943A (en) | 1996-07-30 | 1996-07-30 | Chinese medicinal preparation for treating heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96110885 CN1171943A (en) | 1996-07-30 | 1996-07-30 | Chinese medicinal preparation for treating heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1171943A true CN1171943A (en) | 1998-02-04 |
Family
ID=5120947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 96110885 Pending CN1171943A (en) | 1996-07-30 | 1996-07-30 | Chinese medicinal preparation for treating heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1171943A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101953865B (en) * | 2009-07-16 | 2012-03-21 | 赤峰天奇制药有限责任公司 | Chinese medicinal composition for treating ischemic heart diseases and preparation method thereof |
| CN103393749A (en) * | 2013-07-27 | 2013-11-20 | 李旭红 | Traditional Chinese medicine for preventing and treating ischemic cardiovascular and cerebrovascular diseases |
| CN103751690A (en) * | 2014-01-09 | 2014-04-30 | 李金红 | Traditional Chinese medicine decoction for treating angina and preparation method thereof |
| CN105148200A (en) * | 2015-10-14 | 2015-12-16 | 吴伶 | Traditional Chinese medicine composition for effectively treating coronary heart disease |
| CN109498739A (en) * | 2018-12-04 | 2019-03-22 | 张新元 | A kind of Chinese medicine composition and preparation method thereof for treating heart failure in patients with coronary artery disease |
-
1996
- 1996-07-30 CN CN 96110885 patent/CN1171943A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101953865B (en) * | 2009-07-16 | 2012-03-21 | 赤峰天奇制药有限责任公司 | Chinese medicinal composition for treating ischemic heart diseases and preparation method thereof |
| CN103393749A (en) * | 2013-07-27 | 2013-11-20 | 李旭红 | Traditional Chinese medicine for preventing and treating ischemic cardiovascular and cerebrovascular diseases |
| CN103751690A (en) * | 2014-01-09 | 2014-04-30 | 李金红 | Traditional Chinese medicine decoction for treating angina and preparation method thereof |
| CN103751690B (en) * | 2014-01-09 | 2016-05-04 | 李金红 | One is treated anginal traditional Chinese herbal decoction and preparation method thereof |
| CN105148200A (en) * | 2015-10-14 | 2015-12-16 | 吴伶 | Traditional Chinese medicine composition for effectively treating coronary heart disease |
| CN109498739A (en) * | 2018-12-04 | 2019-03-22 | 张新元 | A kind of Chinese medicine composition and preparation method thereof for treating heart failure in patients with coronary artery disease |
| CN109498739B (en) * | 2018-12-04 | 2021-08-03 | 张新元 | Traditional Chinese medicine composition for treating coronary heart disease and heart failure and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1209121C (en) | Heart-strengthening and blood circulation-promoting liquid medicine for treating heart diseases | |
| CN100382839C (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN1240416C (en) | Medicine for curing hypertension and its preparation method | |
| CN1306951C (en) | Medicine for curing qi deficiency induced thoracic obstruction (coronary heart disease) and technique for preparing the same | |
| CN1171943A (en) | Chinese medicinal preparation for treating heart disease | |
| CN101041006A (en) | Composite Chinese medicine took orally for treating coronary heart disease | |
| CN1030183A (en) | A kind of manufacture method of preventing and treating the coronary heart disease medicine for external use | |
| CN1316988C (en) | Heart disease treating Chinese medicine composition | |
| CN103041119B (en) | One treats cardiopathic Chinese medicine | |
| CN104906274A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN101856455B (en) | Chinese medicament for treating psoriasis vulgaris | |
| CN1947791A (en) | External use traditional Chinese medicine ointment for treating heart diseases | |
| CN1259065C (en) | Chinese medicinal preparation for quick bone fracture setting | |
| CN104800491A (en) | Oral solution with superstrong function of improving human immunity | |
| CN101757329B (en) | Traditional Chinese medicine thrombolysis capsule for treating cerebral thrombosis | |
| CN1175857C (en) | Medicine for preventing and curing cerebrovascular dementia | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN1201751C (en) | Traditional Chinese medicine prepn. for warming heart and inducing arteries and veins contg. ginseng and monkshood | |
| CN111388623B (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN1352959A (en) | Chinese medicine for treating heart disease | |
| CN1242198A (en) | Traditional Chinese medicine capsule for treating coronary heart disease | |
| CN100594916C (en) | Plaster for reducing the blood pressure | |
| CN101773590A (en) | Chinese drug capsule for treatment of coronary heart disease with qi deficiency and blood stasis | |
| CN1318049C (en) | Medicine for treating psoriasis | |
| CN105168653A (en) | Traditional Chinese medicine composition used for treating coronary heart disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |